Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Maravai LifeSciences Holdings, Inc. stock logo
MRVI
Maravai LifeSciences
$2.21
+2.3%
$3.55
$2.07
$11.56
$562.08M-0.082.34 million shs5.18 million shs
National HealthCare Co. stock logo
NHC
National HealthCare
$93.75
+0.2%
$96.04
$87.03
$138.49
$1.45B0.4162,503 shs39,073 shs
Soleno Therapeutics, Inc. stock logo
SLNO
Soleno Therapeutics
$73.67
+7.9%
$50.32
$36.61
$73.97
$3.38B-2.29662,778 shs1.96 million shs
U.S. Physical Therapy, Inc. stock logo
USPH
U.S. Physical Therapy
$72.48
+0.1%
$82.21
$69.99
$112.52
$1.10B1.37103,429 shs95,922 shs
20 High-Yield Dividend Stocks that Could Ruin Your Retirement Cover

Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Maravai LifeSciences Holdings, Inc. stock logo
MRVI
Maravai LifeSciences
+2.31%-6.75%-26.82%-59.74%-74.03%
National HealthCare Co. stock logo
NHC
National HealthCare
+0.19%+1.88%+0.40%-11.96%+9,374,999,900.00%
Soleno Therapeutics, Inc. stock logo
SLNO
Soleno Therapeutics
+7.93%+50.44%+60.85%+61.17%+76.20%
U.S. Physical Therapy, Inc. stock logo
USPH
U.S. Physical Therapy
+0.01%-0.62%-8.61%-17.52%-32.39%
Remove Ads
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Maravai LifeSciences Holdings, Inc. stock logo
MRVI
Maravai LifeSciences
4.5458 of 5 stars
4.13.00.04.42.21.71.3
National HealthCare Co. stock logo
NHC
National HealthCare
N/AN/AN/AN/AN/AN/AN/AN/A
Soleno Therapeutics, Inc. stock logo
SLNO
Soleno Therapeutics
4.6292 of 5 stars
4.61.00.04.62.93.30.6
U.S. Physical Therapy, Inc. stock logo
USPH
U.S. Physical Therapy
3.4615 of 5 stars
3.54.01.70.02.70.81.3
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Maravai LifeSciences Holdings, Inc. stock logo
MRVI
Maravai LifeSciences
2.25
Hold$7.31230.57% Upside
National HealthCare Co. stock logo
NHC
National HealthCare
0.00
N/AN/AN/A
Soleno Therapeutics, Inc. stock logo
SLNO
Soleno Therapeutics
3.22
Buy$98.8634.19% Upside
U.S. Physical Therapy, Inc. stock logo
USPH
U.S. Physical Therapy
3.00
Buy$109.0050.39% Upside

Current Analyst Ratings Breakdown

Latest NHC, MRVI, SLNO, and USPH Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
3/31/2025
Soleno Therapeutics, Inc. stock logo
SLNO
Soleno Therapeutics
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$70.00 ➝ $100.00
3/28/2025
Soleno Therapeutics, Inc. stock logo
SLNO
Soleno Therapeutics
Guggenheim
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$70.00 ➝ $81.00
3/28/2025
Soleno Therapeutics, Inc. stock logo
SLNO
Soleno Therapeutics
Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$74.00 ➝ $108.00
3/27/2025
Soleno Therapeutics, Inc. stock logo
SLNO
Soleno Therapeutics
Laidlaw
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$75.00 ➝ $105.00
3/27/2025
Soleno Therapeutics, Inc. stock logo
SLNO
Soleno Therapeutics
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$67.00 ➝ $123.00
3/27/2025
Soleno Therapeutics, Inc. stock logo
SLNO
Soleno Therapeutics
Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$72.00 ➝ $102.00
3/25/2025
Maravai LifeSciences Holdings, Inc. stock logo
MRVI
Maravai LifeSciences
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetEqual Weight ➝ Equal Weight$7.00 ➝ $5.00
3/21/2025
Maravai LifeSciences Holdings, Inc. stock logo
MRVI
Maravai LifeSciences
Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Price Target$5.00
3/21/2025
Maravai LifeSciences Holdings, Inc. stock logo
MRVI
Maravai LifeSciences
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$8.00 ➝ $2.50
3/19/2025
U.S. Physical Therapy, Inc. stock logo
USPH
U.S. Physical Therapy
JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$120.00 ➝ $110.00
3/5/2025
Soleno Therapeutics, Inc. stock logo
SLNO
Soleno Therapeutics
Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy$74.00
(Data available from 4/3/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Maravai LifeSciences Holdings, Inc. stock logo
MRVI
Maravai LifeSciences
$259.19M2.17$0.05 per share41.71$3.14 per share0.70
National HealthCare Co. stock logo
NHC
National HealthCare
$1.30B1.12$5.98 per share15.68$59.41 per share1.58
Soleno Therapeutics, Inc. stock logo
SLNO
Soleno Therapeutics
N/AN/AN/AN/A$5.16 per shareN/A
U.S. Physical Therapy, Inc. stock logo
USPH
U.S. Physical Therapy
$671.35M1.64$3.93 per share18.46$31.85 per share2.28
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Maravai LifeSciences Holdings, Inc. stock logo
MRVI
Maravai LifeSciences
-$119.03M-$1.02N/AN/AN/A-81.13%-6.61%-3.45%5/6/2025 (Estimated)
National HealthCare Co. stock logo
NHC
National HealthCare
$66.80M$6.5411.75N/A10.03%6.87%4.68%N/A
Soleno Therapeutics, Inc. stock logo
SLNO
Soleno Therapeutics
-$38.99M-$4.26N/AN/AN/AN/A-61.99%-55.21%5/8/2025 (Estimated)
U.S. Physical Therapy, Inc. stock logo
USPH
U.S. Physical Therapy
$28.24M$1.8477.1124.743.543.54%8.11%3.85%5/6/2025 (Estimated)

Latest NHC, MRVI, SLNO, and USPH Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
3/5/2025Q4 2024
Soleno Therapeutics, Inc. stock logo
SLNO
Soleno Therapeutics
-$0.86-$1.27-$0.41-$1.27N/AN/A
2/26/2025Q4 2024
U.S. Physical Therapy, Inc. stock logo
USPH
U.S. Physical Therapy
$0.69$0.65-$0.04$0.52$173.10 million$180.45 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Maravai LifeSciences Holdings, Inc. stock logo
MRVI
Maravai LifeSciences
N/AN/AN/AN/AN/A
National HealthCare Co. stock logo
NHC
National HealthCare
$2.442.60%+4.68%37.31%N/A
Soleno Therapeutics, Inc. stock logo
SLNO
Soleno Therapeutics
N/AN/AN/AN/AN/A
U.S. Physical Therapy, Inc. stock logo
USPH
U.S. Physical Therapy
$1.802.48%+6.43%97.83%N/A

Latest NHC, MRVI, SLNO, and USPH Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
2/14/2025
National HealthCare Co. stock logo
NHC
National HealthCare
quarterly$0.612.36%3/28/20253/28/20254/25/2025
2/26/2025
U.S. Physical Therapy, Inc. stock logo
USPH
U.S. Physical Therapy
Quarterly$0.452.3%3/14/20253/14/20254/11/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Maravai LifeSciences Holdings, Inc. stock logo
MRVI
Maravai LifeSciences
0.89
10.74
9.94
National HealthCare Co. stock logo
NHC
National HealthCare
0.14
1.80
1.77
Soleno Therapeutics, Inc. stock logo
SLNO
Soleno Therapeutics
N/A
17.26
17.26
U.S. Physical Therapy, Inc. stock logo
USPH
U.S. Physical Therapy
0.27
1.78
1.78

Institutional Ownership

CompanyInstitutional Ownership
Maravai LifeSciences Holdings, Inc. stock logo
MRVI
Maravai LifeSciences
50.25%
National HealthCare Co. stock logo
NHC
National HealthCare
56.44%
Soleno Therapeutics, Inc. stock logo
SLNO
Soleno Therapeutics
97.42%
U.S. Physical Therapy, Inc. stock logo
USPH
U.S. Physical Therapy
N/A

Insider Ownership

CompanyInsider Ownership
Maravai LifeSciences Holdings, Inc. stock logo
MRVI
Maravai LifeSciences
0.63%
National HealthCare Co. stock logo
NHC
National HealthCare
13.75%
Soleno Therapeutics, Inc. stock logo
SLNO
Soleno Therapeutics
12.30%
U.S. Physical Therapy, Inc. stock logo
USPH
U.S. Physical Therapy
1.70%
CompanyEmployeesShares OutstandingFree FloatOptionable
Maravai LifeSciences Holdings, Inc. stock logo
MRVI
Maravai LifeSciences
610254.34 million250.94 millionOptionable
National HealthCare Co. stock logo
NHC
National HealthCare
12,40015.45 million13.32 millionN/A
Soleno Therapeutics, Inc. stock logo
SLNO
Soleno Therapeutics
3045.86 million37.81 millionOptionable
U.S. Physical Therapy, Inc. stock logo
USPH
U.S. Physical Therapy
6,14015.19 million14.84 millionOptionable

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Maravai LifeSciences stock logo

Maravai LifeSciences NASDAQ:MRVI

$2.21 +0.05 (+2.31%)
Closing price 04/2/2025 04:00 PM Eastern
Extended Trading
$2.14 -0.07 (-3.17%)
As of 04/2/2025 07:48 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases worldwide. The company's products address the key phases of biopharmaceutical development and include nucleic acids for diagnostic and therapeutic applications, antibody-based products to detect impurities during the production of biopharmaceutical products, and products to detect the expression of proteins in tissues of various species. It operates in two segments, Nucleic Acid Production and Biologics Safety Testing. The Nucleic Acid Production segment manufactures and sells products for use in the fields of gene therapy, vaccines, nucleoside chemistry, oligonucleotide therapy, and molecular diagnostics, including reagents used in the chemical synthesis, modification, labelling, and purification of deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). This segment also offers messenger RNA, oligonucleotides, and oligonucleotide building blocks, as well as custom enzyme development and manufacturing and CleanCap capping technology. The Biologics Safety Testing segment sells analytical products for use in biologic manufacturing process development, including custom product-specific development antibody, and assay development services. This segment also provides HCP ELISA kits, other bioprocess impurity and contaminant ELISA kits, ancillary reagents, viral clearance prediction kits, and custom services. The company serves biopharmaceutical companies, and other biopharmaceutical and life sciences research companies; and academic research institutions and in vitro diagnostics companies. The company was incorporated in 2020 and is headquartered in San Diego, California.

National HealthCare stock logo

National HealthCare NYSE:NHC

$93.75 +0.18 (+0.19%)
As of 04/2/2025 04:00 PM Eastern

National HealthCare Corporation engages in the operation of services to skilled nursing facilities, assisted and independent living facilities, homecare and hospice agencies, and health hospitals. Its skilled nursing facilities offer licensed therapy services, nutrition services, social services, activities, and housekeeping and laundry services, as well as medical services prescribed by physicians; and rehabilitative services, such as physical, speech, respiratory, and occupational therapy for patients recovering from strokes, heart attacks, orthopedic conditions, neurological illnesses, or other illnesses, injuries, or disabilities. The company's medical specialty units comprise memory care units and sub-cute nursing units that provide specialized care and programs for persons with Alzheimer's or related disorders; and assisted living facilities offer personal care services and assistance with general activities of daily living, such as dressing, bathing, meal preparation, and medication management. Its independent living facilities offers specially designed residential units for the active and ambulatory elderly and provide various ancillary services for residents, including restaurants, activity rooms and social areas; and behavioral health services to both adults and geriatric patients with psychiatric, emotional, and addictive disorders. In addition, the company's homecare agencies assist those who wish to stay at home or in assisted living residences but still require some degree of medical care or assistance with daily activities; hospice agencies that provides hospice and palliative care; and operates pharmacies, as well as managed care insurance solutions. Further, it offers management, accounting, and financial services; and leases its properties to third party operators. The company was founded in 1971 and is based in Murfreesboro, Tennessee.

Soleno Therapeutics stock logo

Soleno Therapeutics NASDAQ:SLNO

$73.67 +5.41 (+7.93%)
Closing price 04/2/2025 04:00 PM Eastern
Extended Trading
$71.38 -2.30 (-3.12%)
As of 04/2/2025 07:49 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Soleno Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its lead candidate is Diazoxide Choline Extended-Release tablets, a once-daily oral tablet, which is in Phase III clinical trials for the treatment of Prader-Willi Syndrome. The company was formerly known as Capnia, Inc. and changed its name to Soleno Therapeutics, Inc. in May 2017. Soleno Therapeutics, Inc. was incorporated in 1999 and is based in Redwood City, California.

U.S. Physical Therapy stock logo

U.S. Physical Therapy NYSE:USPH

$72.48 +0.10 (+0.14%)
Closing price 04/2/2025 03:58 PM Eastern
Extended Trading
$72.47 -0.01 (-0.01%)
As of 04/2/2025 04:49 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

U.S. Physical Therapy, Inc. operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries. It offers industrial injury prevention services, including onsite injury prevention and rehabilitation, performance optimization, post-offer employment testing, functional capacity evaluations, and ergonomic assessments through physical therapists and specialized certified athletic trainers for Fortune 500 companies, and other clients comprising insurers and their contractors. U.S. Physical Therapy, Inc. was founded in 1990 and is based in Houston, Texas.